Key takeaways The FDA approved the first generic GLP-1 specifically indicated for weight loss, a version of the popular injectable medication, Saxenda
Various 0 minutes 1-2 Weeks Office Intravenous treatments involve injecting vitamins, minerals, amino acids, antioxidants, and other natural biologic compounds directly into the bloodstream
Rushing escalation or skipping titration steps dramatically increases nausea, vomiting, and gastrointestinal distress
Plans that previously had higher approval rates saw approvals drop to match eviCore's stricter criteria
Document your chosen time and site in a calendar or smartphone app to ensure accountability and track any patterns between timing and side effect severity
The medication follows a structured dose-escalation schedule over 17 weeks, starting at 0.25 mg and increasing to the 2.4 mg maintenance dose